tiprankstipranks
Advertisement

XJR - ETF AI Analysis

Compare

Top Page

XJR

iShares ESG Screened S&P Small-Cap ETF (XJR)

Rating:66Neutral
Price Target:
XJR, the iShares ESG Screened S&P Small-Cap ETF, has a solid overall rating supported by strong holdings like Krystal Biotech and Alkermes, which show robust financial performance, strategic growth initiatives, and positive earnings call sentiment. The rating is tempered by weaker names such as ViaSat and Glaukos, where profitability challenges, high leverage, and valuation concerns add risk. A key risk factor for XJR is its exposure to several small-cap companies with high valuations and leverage, which can make the fund more sensitive to market volatility and short-term pullbacks.
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and over the past month, indicating positive recent momentum.
Broad Sector Diversification
Holdings are spread across many sectors, including financials, technology, industrials, and consumer-related areas, which helps reduce the impact of weakness in any single industry.
Low Expense Ratio
The fund charges a relatively low management fee, which helps investors keep more of their returns over time.
Negative Factors
Heavy U.S. Concentration
With nearly all assets invested in U.S. companies, the ETF offers little geographic diversification and is highly tied to the U.S. economy.
Small-Cap Volatility Risk
Because the fund focuses on smaller companies, its share price may move up and down more sharply than funds holding larger, more established firms.
Limited Impact of Individual Winners
Each top holding makes up only a small slice of the portfolio, so even strongly performing stocks have a limited effect on overall returns.

XJR vs. SPDR S&P 500 ETF (SPY)

XJR Summary

The iShares ESG Screened S&P Small-Cap ETF (XJR) tracks the S&P SmallCap 600 Sustainability Screened Index, focusing on smaller U.S. companies that meet certain environmental, social, and governance (ESG) standards. It holds a wide mix of sectors like financials, technology, and industrials, with stocks such as Lumen Technologies and LKQ in the portfolio. Someone might invest in XJR to seek long-term growth from small, potentially fast-growing companies while also supporting more sustainable business practices. A key risk is that small-cap stocks can be more volatile, so the ETF’s price can move up and down sharply with the market.
How much will it cost me?The iShares ESG Screened S&P Small-Cap ETF (XJR) has an expense ratio of 0.12%, which means you’ll pay $1.20 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking an index rather than relying on active management.
What would affect this ETF?The iShares ESG Screened S&P Small-Cap ETF (XJR) could benefit from growing interest in ESG investing and the innovative potential of small-cap companies, particularly in sectors like technology and industrials. However, it may face challenges from economic slowdowns, rising interest rates, or regulatory changes that impact small-cap firms disproportionately. Its focus on U.S. companies also makes it sensitive to domestic economic conditions and policy shifts.

XJR Top 10 Holdings

XJR’s story is all about U.S. small caps with an ESG twist, and lately its leaders have been in the industrial and health care lanes. Argan and Element Solutions are rising, giving the fund a lift from the industrial side, while Alkermes and Krystal Biotech are helping health care pull its weight. Financial name StoneX Group is also climbing, adding some steady ballast. The main drag comes from ViaSat, which has been lagging despite earlier gains. Overall, the ETF is diversified across sectors but leans into U.S. industrials, tech, and health care innovators.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Molina Healthcare0.73%$1.16M$11.98B-2.11%
71
Outperform
ViaSat0.70%$1.11M$11.34B426.05%
56
Neutral
BrightSpring Health Services, Inc.0.69%$1.09M$13.55B229.10%
67
Neutral
Argan0.62%$987.76K$9.90B227.45%
73
Outperform
Krystal Biotech0.60%$958.81K$11.06B157.16%
80
Outperform
Element Solutions0.60%$945.34K$10.63B71.61%
65
Neutral
Formfactor0.57%$902.37K$9.63B196.15%
68
Neutral
Alkermes0.57%$896.74K$9.10B87.95%
80
Outperform
Esco Technologies0.55%$865.62K$8.62B77.64%
70
Neutral
Match Group0.54%$857.37K$8.84B18.35%
66
Neutral

XJR Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
49.42
Positive
100DMA
47.18
Positive
200DMA
45.06
Positive
Market Momentum
MACD
0.78
Positive
RSI
52.13
Neutral
STOCH
33.53
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XJR, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 51.14, equal to the 50-day MA of 49.42, and equal to the 200-day MA of 45.06, indicating a neutral trend. The MACD of 0.78 indicates Positive momentum. The RSI at 52.13 is Neutral, neither overbought nor oversold. The STOCH value of 33.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for XJR.

XJR Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$185.62M0.12%
66
Neutral
$878.38M0.48%
72
Outperform
$719.92M0.38%
67
Neutral
$713.08M0.09%
64
Neutral
$695.85M0.40%
69
Neutral
$681.96M0.42%
68
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
XJR
iShares ESG Screened S&P Small-Cap ETF
50.95
10.62
26.33%
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
EES
WisdomTree U.S. SmallCap Fund
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
SMDV
ProShares Russell 2000 Dividend Growers ETF
JHSC
John Hancock Multifactor Small Cap ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement